retatrutide weight loss clinical trials results New Phase 3 data just dropped 👀 Eli Lilly's trial reported average approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Retatrutide trial results in 28

These changes vary based on individual factors including starting weight, total weight lost, age, and skin quality

Both groups underwent lifestyle modification interventions

UBT251 is classified as a Class 1 innovative drug in China and has recently been approved for clinical trials in adults with type 2 diabetes, fatty liver disease, and chronic kidney disease

The dysesthesia side effect Approximately 12.5% of participants on the highest dose of retatrutide experienced dysesthesia, or abnormal skin sensations, including a burning, tingling or pins and needles sensation

However, weight loss, especially large amounts in short periods of time, isnt all sunshine

Safe than sorry is a good practice when it comes to your health